The number of patients who require maintenance on anticoagulation therapy (warfarin/Coumadin ®) for minimizing risk of cardiovascular events like stroke or thromboembolism is increasing.

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

"The results we reviewed here have significant implications for optimizing anticoagulation therapy and improving patient outcomes in clinical practice," said Behnood Bikdeli, MD, MS, of the Brigham's ...

Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

which could address significant unmet needs in the anticoagulation therapy market. Trending Articles AcelRx Pharmaceuticals NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Left atrial appendage occlusion vs continuation of oral anticoagulation therapy alone is linked to reduced ischemic stroke risk in select patients with nonvalvular AF.

It was safe to start direct oral anticoagulant (DOAC) therapy without delay after acute ischemic stroke in people with atrial ...

Participation Reinforces Cadrenal's Commitment to Innovation, Education and Improved Patient Outcomes with Anticoagulation Therapy PONTE VEDRA, Fla., Oct. 23, 2024 /PRNewswire/ -- Cadrenal ...

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...